First of three parts As Dr. Lynn Bornfriend puts it, she was “absolutely no fun” in the 1970s and 1980s, when many of her peers were dabbling in recreational marijuana. “I didn’t touch marijuana,” said Bornfriend, a psychiatrist at the Cancer Treatment Centers of America in Philadelphia. “I didn’t want to talk to people who […]

by

You don’t need me to tell you that CBD (cannabidiol) is everywhere. You can eat it, you can drink it, you can vape it, you can even bathe in it. And, although there’s still plenty to learn about this fascinating little compound, fans of it claim that it has some pretty impressive benefits—particularly when it […]

by

‘+ ‘ ‘+__tnt.truncateStr(oAsset.title.replace(/(]+))/ig,””),iTextTrun,’…’)+’ ‘+ ‘ ‘+__tnt.truncateStr(oAsset.summary.replace(/(]+))/ig,””),iTextTrun,’…’)+’ ‘+ ‘ … read more at: http://www.indexjournal.com/news/greenwood-center-research-involved-in-experimental-drug-trial/article_65752454-fd67-59c8-a820-7798d1f16cf6.html

by

Dravet syndrome is a distressing infantile-onset epilepsy, which is sometimes accompanied by severe intellectual disabilities, autistic traits, hyperactive behavior, and ataxia. Discovery of SCN1A mutation in 2001 as a primary cause of this syndrome has accelerated the knowledge of the pathophysiological processes behind Dravet syndrome. SCN1A is responsible for encoding the α-subunit of the voltage-gated […]

by

Nascent industries face a host of challenges, especially when government agencies send conflicting messages to the public on safety. Recently the city’s Department of Health and Mental Hygiene embargoed popular hemp products in stores without warning. In the media, the incidents resembled old-time drug busts, creating an unsafe impression of cannabidiol, which is extracted from […]

by

Salient Capital Advisors Llc decreased its stake in Genesis Energy LP (GEL) by 6.34% based on its latest 2018Q4 regulatory filing with the SEC. Salient Capital Advisors Llc sold 419,623 shares as the company’s stock declined 2.69% while stock markets rallied. The institutional investor held 6.20M shares of the energy company at the end of […]

by

Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) has earned an average recommendation of “Buy” from the six ratings firms that are presently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month price objective among brokerages that have […]

by

© iStock/OlegMalyshev Discover CanaQuest’s strong commitment to research that enables it to develop safer medical cannabis products and formulations. With 40+ countries around the world now having legalised the use of cannabis for medical purposes to some degree, news headlines are dominated by the potential size of the global market, along with the medical cannabis […]

by

UC Berkeley synthetic biologists have engineered brewer’s yeast to produce marijuana’s main ingredients—mind-altering THC and non-psychoactive CBD—as well as novel cannabinoids not found in the plant itself. Feeding only on sugar, the yeast are an easy and cheap way to produce pure cannabinoids that today are costly to extract from the buds of the marijuana […]

by

Porvair Sciences reports on a highly effective protocol, using its Plant Genomics microplate, for preparing cannabis samples for analysis of Tetrahydrocannabinol (THC) and Cannabidiol (CBD). With increasing legalization of cannabis for medicinal and research purposes, demand for accurate and high throughtput analysis of its active ingredients has dramatically risen. Cannabis plant material contains several cannabinoids […]

by

Aridis Pharmaceuticals Inc. (NASDAQ:ARDS) and Intec Pharma Ltd. (NASDAQ:NTEC) compete with each other in the Biotechnology sector. We will analyze and compare their profitability, institutional ownership, analyst recommendations, risk, dividends, earnings and valuation. Valuation and Earnings Table 1 highlights Aridis Pharmaceuticals Inc. and Intec Pharma Ltd.’s gross revenue, earnings per share and valuation. Profitability Table […]

by